Alzheimer’s Disease Clinical Trials

Home | Studies | Alzheimer’s Disease

Do Something Unforgettable Today & Participate in a Clinical Research Study to Prevent Alzheimer’s Disease.

Alzheimer disease’s pathophysiology begins a decade before it starts showing any clinical symptoms. Many studies show that starting intervention in earlier stages may have greater benefit. Despite studies to date, there is not an approved medication for preclinical Alzheimer’s. Hence, there is a need to find preventive and advanced treatment options.

Neurologists all over the US are trying to find preventive treatment for this condition in early development of the disease. Revival Research Institute is conducting a Clinical Trial to prevent Alzheimer’s Disease, evaluating the safety and effectiveness of an investigational drug for those at risk of Alzheimer’s disease.

You maybe eligible to participate in this study if you:

Are between 65 to 80 years of age
Have normal memory, thinking, mood and behavior patterns
Have a reliable *study partner who knows you and is willing to attend appointments with you throughout the study

*The study partner must be able to speak about the participant’s day to day routines and any changes with the research staff throughout the study.

This Clinical Trial is being conducted to intervene Alzheimer’s onset in its earlier stages and stop it from progressing to clinical stages.

*Participating in our Alzheimer’s Disease Clinical Trials will be no cost. To see if you’re eligible for the study, fill out the form. Our study team will contact you and inquire about your medical history and current medications. If you are eligible for the study and choose to participate, our study team will guide you about the study.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By Signing up, I agree to be contacted via calls and SMS.

About the Alzheimer’s Disease Clinical Trials

We are conducting a double blind, placebo-controlled, Phase 3 study on an experimental drug in unimpaired participants with evidence of Alzheimer’s Disease pathology. Approximately 3,300 participants will be participating. Study visits will be conducted remotely, whole or in part. All cognitive assessments will be conducted remotely.

This study is divided into 3 study periods: Screening, Study Treatment, and Observation period. You will be given the study drug intravenously that means it will be infused through a vein in your arm.

*Participants who receive placebo in the treatment phase and complete the observation phase, may have access to the investigational treatment in an open label extensions.

There will be no better therapies, prevention, or treatment for Alzheimer’s disease without clinical trials. You may contribute to speed up the development and give crucial insight into possible therapies and preventative approaches by participating in clinical research such as the Alzheimer Research Clinical Trials. All trial participants receive ongoing care and have the chance to receive care from experienced professionals.

*If you meet the criteria and want to participate in the study, you will be compensated for your time and travel.

Get Started: What to Expect?

To see if you qualify for the Alzheimer’s study, please fill out your information in the form above and one of our representatives will contact you. If you do qualify for the Alzheimer Research Clinical Trials, you will be invited to our study site for a screening visit. After further screenings, if you qualify, you will be asked to sign an informed consent form. Once it’s signed, you will be asked health-related questions and several health assessments and tests will be conducted to help determine if you are eligible as a volunteer for this study.

You will be randomly allocated to one of two research groups when you sign the consent form and meet all of the study requirements of the Alzheimer’s Disease Clinical Trials. Each participant has a 50 percent chance of being selected for one of the two research groups. One group will be given a placebo (medication that does not contain the active component in the study treatment), while the other will be given the study drug (active ingredient).

*Participation in the research study is completely voluntary. Every participant has the right to withdraw from the study at any time in the duration of the study.

Condition

Alzheimer’s Disease

Length Of Study Treatment:

Approximately 4 years

Age:

65 – 80 years

About Alzheimer’s Disease

Alzheimer’s disease is a neurologic illness that results in the death of brain cells. Memory, reasoning, and attitude are all affected by this type of dementia. The symptoms eventually worsen to the point that they impede regular activities. It is a progressive deterioration of a person’s intellectual, emotional, and social skills that impairs their capacity to function independently.

Progression of Alzheimer’s Disease

Changes in the brain that affect learning are typical of Alzheimer’s disease. As Alzheimer’s disease progresses through the brain, more severe symptoms emerge, such as disorientation, mood, and behavioral changes; increasing confusion about events, time, and place; unfounded suspicions about family, friends, and professional caregivers; more serious memory loss and behavioral issues; and difficulty speaking, swallowing, and walking.

Treatment

Medications can temporarily improve or reduce the severity of symptoms. These medicines can possibly enable persons with Alzheimer’s disease to temporarily preserve their independence and improve their function. People with Alzheimer’s disease and their caregivers can benefit from a variety of services and programs.

Alzheimer’s disease has no cure or treatment that alters the progression of the disease in the brain. Complications from severe loss of brain function, such as dehydration, starvation, or infection, can lead to death in later stages of the condition.

Frequently Asked Questions (FAQs)

What is the main cause of Alzheimer’s Disease?

Alzheimer’s disease is caused by the build-up of proteins around the brain cells. Two of the most common proteins include Tau and Amyloid. These protein deposits are called plaque and tangles. Alzheimer’s is a slowly progressive disease and depends upon the build up of these proteins, which over time increases and cognitive function declines.

How can I prevent Alzheimer’s Disease?

Healthy lifestyle changes are the best ways that may decrease the progressiveness of the condition. These include stopping smoking, reducing alcohol consumption, eating a healthy, balanced diet, and exercising. Another option is to look into other options like the Alzheimer’s Disease Clinical Trials that explore a potential investigational treatment to delay or prevent the onset of Alzheimer’s.

Where will the Alzheimer’s Disease Clinical Trials take place?

Alzheimer Research Clinical Trials are being conducted all over the US. Revival Research Institute is conducting these research studies in a 50-mile location near you in Michigan. To learn more or to participate, please fill the form above. Someone from our research staff will contact you and give you details about the study site’s location.